| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/15/2004 | US20040072741 Tribonectin polypeptides and uses thereof |
| 04/15/2004 | US20040072739 Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes |
| 04/15/2004 | US20040072738 Analogues of thiocoraline and be-22179 |
| 04/15/2004 | US20040072737 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents |
| 04/15/2004 | US20040072736 First cyclic group, which contains a cysteine group, is formed by an amide bonding of the N-terminal amino acid with the second carboxylate group of a diacid amino acid, and a second cyclic group with amide bonding of alpha-carboxylate |
| 04/15/2004 | US20040072735 Administering suberoylanilide hydroxamic acid (SAHA) to inhibit histone deacetylase (HDAC) to a patient for cancer cell growth arrest and/or apoptosis of neoplastic cells |
| 04/15/2004 | US20040072734 Administering a therapeutically effective amount of H-Cys-Phe-Phe-D-Trp-Lys-Thr-Phe-Cys-NH2, wherein a disulfide bond exists between the free thiols of two cysteine residue |
| 04/15/2004 | US20040072732 Inhibiting relapse of antibiotic-associated diarrhea in a patient by administering ramoplanin in an amount and for a duration effective to inhibit relapse of antibiotic associated diarrhea in the patient |
| 04/15/2004 | US20040072731 Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin |
| 04/15/2004 | US20040072730 Composition for synthetic cervical mucus formulation |
| 04/15/2004 | US20040072729 Administering PEG-hemoglobin (polyethylene glycol-conjugated hemoglobin) solution with specific ability to deliver oxygen to cells of a mammal under ischemia or hypoxia |
| 04/15/2004 | US20040072728 Use of streptavidin to inhibit transplant rejection |
| 04/15/2004 | US20040072726 Decoy is an NF- kappa B decoy, an ets decoy, or a chimera decoy of NF- kappa B and ets. The disease is cerebral aneurysm, cancer, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic etc. |
| 04/15/2004 | US20040072346 Transgenic neuronal tissue for propagation and treatment of brain disorders; tissue engineering and gene therapy |
| 04/15/2004 | US20040072319 Molecules that modulate ubiquintin-dependent proteolysis and methods for identifying same |
| 04/15/2004 | US20040072317 Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses |
| 04/15/2004 | US20040072315 Integrin-binding chimeras |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072298 Comprises homeobox gene protein for enhancing hematopoietic stem cell expansion by direct delivery of protein to cell; gene therapy |
| 04/15/2004 | US20040072294 Generating morphogens associated with extracellular matrix for reconstructing damaged or injured tissues; tissue engineering |
| 04/15/2004 | US20040072292 Comprises nucleotide sequences coding goose-type lysozyme (LYG2) for diagnosis, treatment and prevention of autoimmune, inflammatory, renal, adrenal and cancer disorders |
| 04/15/2004 | US20040072291 Comprises genetically engineered nerve growth factor for diagnosis and treatment of nervous system and neurodegenerative disease |
| 04/15/2004 | US20040072286 Comprises nucleotide sequences coding synovium/cartilage inflammation-linked messenger 1 (SCIM-1) for diagnosis and treatment of rhematoid arthritis |
| 04/15/2004 | US20040072285 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 04/15/2004 | US20040072283 Rapid immunoselection cloning method |
| 04/15/2004 | US20040072258 Disruption of a Ras-protein complex by a Ras antagonist, e.g.,farensylthiosalicylic acid, analyzed; identifying drug candidates inhibiting aberrant Ras activity; binding andinactivating mRNA of anchor protein by a oligonucleotides |
| 04/15/2004 | US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses |
| 04/15/2004 | US20040072253 Novel protein and DNA thereof |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072236 PrPSc -interacting molecules and uses thereof |
| 04/15/2004 | US20040072227 Integrin ligand, human mindin |
| 04/15/2004 | US20040072222 A conformational model of linear epitope sequence from guinea pig MBP72-85 and human MBP87-99 |
| 04/15/2004 | US20040072219 Genetically engineered obesity protein with reduced immune response for treatment of diabetes, high blood pressure and cholesterol metabolism disorders |
| 04/15/2004 | US20040072214 Novel glycoproteins and methods of use thereof |
| 04/15/2004 | US20040072210 Reagents and methods useful for detecting diseases of the breast |
| 04/15/2004 | US20040072196 Novel serpentine transmembrane antigens expressed in human cancers and uses therefor |
| 04/15/2004 | US20040072194 Vasodilation polypeptide for diagnosis and treatment of vascular and cardiovascular system disorders |
| 04/15/2004 | US20040072192 Cancer-linked genes as targets for chemotherapy |
| 04/15/2004 | US20040072190 Hydrolases |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072185 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses |
| 04/15/2004 | US20040072183 Comprises biodegradable bioahesive polypeptide exhibiting von willebrand factor like protein domains for use in moist conditions, wound healing and plastic surgery; sutures |
| 04/15/2004 | US20040072182 Methods and compositions for detecting target sequences |
| 04/15/2004 | US20040072175 Comprises kinesin for identifying herbicides, insecticides or fungicides which improve food and/or fiber crop production |
| 04/15/2004 | US20040072174 Calpain protease 12 |
| 04/15/2004 | US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy |
| 04/15/2004 | US20040072170 Using creatine kinase messenger RNA expression profiles to diagnose congestive heart failure |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072168 Novel deoxynucleoside kinase enzyme variants |
| 04/15/2004 | US20040072163 Comprises polynucleotide coding cell death regulatory proteins for diagnosis, prevention and treatment of tumors, tissue necrosis, autoimmune, skin and nervous system disordere |
| 04/15/2004 | US20040072162 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 04/15/2004 | US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 04/15/2004 | US20040072146 Using peptide modulator to prevent associations between adenine nucleotide translocator (ANT) and viral replication proteins (VPR); antiapoptosis |
| 04/15/2004 | US20040071787 Pharmacologic, therapeutic and diagnostic regulation of FGF-1 export |
| 04/15/2004 | US20040071770 Free radical scavenging liposome containing mixture of beta-carotene, vitamin E, vitamin C, glutathione, niacin, and/or trace metal; quenching |
| 04/15/2004 | US20040071766 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 04/15/2004 | US20040071749 DNA or protein biosynthesis in dermal cells; topically applied |
| 04/15/2004 | US20040071738 Hypo-allergenic pollen protein treated with thioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) |
| 04/15/2004 | US20040071735 Bone and muscular disorder treatment |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071730 Polypeptides and polynucleotides; genetic engineering; medical diagnosis |
| 04/15/2004 | US20040071727 Method of vaccinating vertebrates |
| 04/15/2004 | US20040071726 Presenting mammalian antigen-presenting cell (APC) cell line transfected with DNA encoding polypeptide; isolating class II major histocompatability complex(MHC) molecule bound to peptide; elution; classification; cancer diagnosis |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071723 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071722 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071717 Recombinant DNA encoding the major allergen of plantago lanceolata pollen, Pla I 1, and applications thereof |
| 04/15/2004 | US20040071714 A gene expressed polypeptide is used in food, for treating food allergy |
| 04/15/2004 | US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071707 Modulation of cell growth |
| 04/15/2004 | US20040071706 An antibody for treating Crohn's disease and ulcerative colitis, inhibit the transduction of biological activity of cytokine, B-cell differentiation factors |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071697 Reducing epithelial toxicity during cancer therapy |
| 04/15/2004 | US20040071693 Humanised antibodies |
| 04/15/2004 | US20040071692 Minimizes toxicity to normal tissue; high therapeutic index |
| 04/15/2004 | US20040071691 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity |
| 04/15/2004 | US20040071690 High avidity polyvalent and polyspecific reagents |
| 04/15/2004 | US20040071688 Reduced or removed potential T cell epitopes |
| 04/15/2004 | US20040071687 Adult stem cell recruitment |
| 04/15/2004 | US20040071686 Treatment of alpha-galactosidase A deficiency |
| 04/15/2004 | US20040071685 Compositions and methods for increasing the bioavailability of plant polyphenols |
| 04/15/2004 | US20040071684 Overcoming persistent epithelial defects; preventing recurrent erosion |
| 04/15/2004 | US20040071683 Methods for treating pervasive development disorders |
| 04/15/2004 | US20040071682 Super absorption coenzyme Q10 |
| 04/15/2004 | US20040071677 Nephritis treatment by gene therapy |
| 04/15/2004 | US20040071676 Yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
| 04/15/2004 | US20040071675 Retrograde transport delivering entity of interest to tyrosine hydroxylase positive neuron; Parkinson's disease; rabies g protein transduction |
| 04/15/2004 | US20040071674 Directly implanting; permanent engrafting; stably expressing variety of gene products; differentiating into specialized cells; nitric oxide synthase |
| 04/15/2004 | US20040071673 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 04/15/2004 | US20040071671 Cell therapy method for the treatment of tumors |
| 04/15/2004 | US20040071669 Transplants for myocardial scars |
| 04/15/2004 | US20040071666 Compositions and methods related to graft-versus-host disease |
| 04/15/2004 | US20040071663 Pesticidal and antiparasitic compositions |